share_log

MBX Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-Wellington Biomedical Innovation Master Investors (Cayman) II, L.P.(5.62%)

MBX Biosciences | SC 13G:超过5%持股股东披露文件-Wellington Biomedical Innovation Master Investors (Cayman) II, L.P.(5.62%)

美股SEC公告 ·  09/20 22:17
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息